These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4219497)

  • 1. Laboratory techniques in rabies: the antibody binding test for vaccine potency.
    Arko RJ; Wiktor TJ; Sikes RK
    Monogr Ser World Health Organ; 1973; (23):292-4. PubMed ID: 4219497
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model.
    Bruckner L; Kihm U
    Dev Biol Stand; 1986; 64():93-7. PubMed ID: 3792660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an in vitro assay for the determination of rabies antigen.
    Barth R; Gruschkau H; Milcke L; Jaeger O; Weinmann E
    Dev Biol Stand; 1986; 64():87-92. PubMed ID: 3792659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro seroneutralization of rabies virus in Leighton tubes, evaluated by immunofluorescence inhibition].
    Seroka D; Labuńska E
    Med Dosw Mikrobiol; 1981; 33(1):67-72. PubMed ID: 7024687
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines].
    Seroka D; Wysokińska T
    Med Dosw Mikrobiol; 1982; 34(1-2):61-71. PubMed ID: 7144329
    [No Abstract]   [Full Text] [Related]  

  • 8. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
    Ferguson M; Seagroatt V; Schild GC
    Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rabies vaccine in Czechoslovakia. I. Hempt's vaccine and its modification].
    Slonim D; Stastný F; Brázdová AR
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):257-65. PubMed ID: 6215991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advances in the production and control of human rabies vaccine].
    Serokowa D
    Przegl Epidemiol; 1979; 33(1):42-54. PubMed ID: 451242
    [No Abstract]   [Full Text] [Related]  

  • 11. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rabies antibody production in ferrets after immunization with four different rabies vaccines].
    Mainka C
    Zentralbl Veterinarmed B; 1994 Nov; 41(9):574-9. PubMed ID: 7740856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies treatment with vaccine of the Fuenzalida-Palacios type.
    Fábrega FP; Sepúlveda CA
    Bull Pan Am Health Organ; 1982; 16(1):40-6. PubMed ID: 7074254
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study on antibody determination by different methods in sera of persons vaccinated with HDCS-vaccine.
    Kuwert EK; Thraenhart O; Marcus I; Werner J; Atanasiu P; Bahmanyar M; Bögel K; Cox JH; Schneider LG; Turner G; Wiktor TJ
    Zentralbl Bakteriol Orig A; 1978 Oct; 241(4):395-406. PubMed ID: 735548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs.
    Bankovskiy D; Safonov G; Kurilchuk Y
    Dev Biol (Basel); 2008; 131():461-6. PubMed ID: 18634508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.